Correlation between mesenteric fat thickness and serum apolipoproteins in patients with peripheral arterial occlusive disease

Lipids in Health and Disease

Volumn 11, Issue , 2012, Pages

  Perelas, Apostolos ^a   Safarika, Vanessa ^b   Vlachos, Ioannis S ^a   Tzanetakou, Irene ^a   Korou, Laskarina Maria ^a   Konstantopoulos, Panagiotis ^a   Doulamis, Ilias ^a   Ioannidis, Ioannis ^b   Kornezos, Ioannis ^b   Gargas, Dimitrios ^b   Klonaris, Christos ^a   Perrea, Despina N ^a   Chatziioannou, Achilleas ^b  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

Adipose tissue; Apolipoproteins; Atherosclerosis; Mesenteric fat thickness; Ultrasound

Indexed keywords

APOLIPOPROTEIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; APOLIPOPROTEIN B; APOLIPOPROTEIN C2; APOLIPOPROTEIN C3; APOLIPOPROTEIN E;

ADULT; ANGIOPLASTY; ARTICLE; BODY FAT; BODY MASS; CLINICAL ARTICLE; CORRELATION ANALYSIS; DIGITAL SUBTRACTION ANGIOGRAPHY; DYSLIPIDEMIA; FEMALE; HUMAN; HYPERTENSION; MALE; MESENTERIC FAT THICKNESS; MESENTERY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PROTEIN BLOOD LEVEL; THICKNESS; UMBILICUS;

AGED; APOLIPOPROTEINS; ARTERIAL OCCLUSIVE DISEASES; FEMALE; HUMANS; INTRA-ABDOMINAL FAT; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PERIPHERAL ARTERIAL DISEASE;

EID: 84866790301     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-11-125     Document Type: Article

References (34)

1. The international obesity task force and "globesity". Deitel M, Obes Surg 2002 12 613 614 10.1381/096089202321019558 12448379
2. Global burden of obesity in 2005 and projections to 2030. Kelly T, Yang W, Chen CS, Reynolds K, He J, Int J Obes (Lond) 2008 32 1431 1437 10.1038/ijo.2008.102
3. The disease burden associated with overweight and obesity. Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH, JAMA 1999 282 1523 1529 10.1001/jama.282.16.1523 10546691
4. Visceral adipose tissue and atherosclerosis. Ohman MK, Wright AP, Wickenheiser KJ, Luo W, Eitzman DT, Curr Vasc Pharmacol 2009 7 169 179 10.2174/157016109787455680 19356000
5. Sonographic assessment of regional adiposity. Vlachos IS, Hatziioannou A, Perelas A, Perrea DN, AJR Am J Roentgenol 2007 189 1545 1553 10.2214/AJR.07.2366 18029899
6. Apolipoprotein measurements: is more widespread use clinically indicated? Davidson MH, Clin Cardiol 2009 32 482 486 10.1002/clc.20559 19743499
7. HDL: bridging past and present with a look at the future. Scanu AM, Edelstein C, FASEB J 2008 22 4044 4054 10.1096/fj.08-117150 18716026
8. Influence of apolipoproteinCII concentrations on HDL subclass distribution. Tian L, Xu Y, Fu M, Jia L, Yang Y, J Atheroscler Thromb 2009 16 611 620 10.5551/jat.1156 19729871
9. Apolipoprotein CIII links dyslipidemia with atherosclerosis. Kawakami A, Yoshida M, J Atheroscler Thromb 2009 16 6 11 10.5551/jat.E607 19262004
10. Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E. Mahley RW, Ji ZS, J Lipid Res 1999 40 1 16 9869645
11. Biological specificity of visceral adipose tissue and therapeutic intervention. Perrini S, Leonardini A, Laviola L, Giorgino F, Arch Physiol Biochem 2008 114 277 286 10.1080/13813450802334752 18946788
12. Adipocytokines and obesity-linked disorders. Ouchi N, Ohashi K, Shibata R, Murohara T, Nagoya J Med Sci 2012 74 19 30 22515108
13. Mesenteric fat thickness is an independent determinant of metabolic syndrome and identifies subjects with increased carotid intima-media thickness. Liu KH, Chan YL, Chan WB, Chan JC, Chu CW, Diabetes Care 2006 29 379 384 10.2337/diacare.29.02.06.dc05-1578 16443891
14. Accuracy, reproducibility and repeatability of ultrasonography in the assessment of abdominal adiposity. Bazzocchi A, Filonzi G, Ponti F, Sassi C, Salizzoni E, Battista G, Canini R, Acad Radiol 2011 18 1133 1143 10.1016/j.acra.2011.04.014 21724427
15. Association of carotid intima-media thickness with mesenteric, preperitoneal and subcutaneous fat thickness. Liu KH, Chan YL, Chan JC, Chan WB, Atherosclerosis 2005 179 299 304 10.1016/j.atherosclerosis.2004.10.038 15777545
16. Mesenteric fat thickness as an independent determinant of fatty liver. Liu KH, Chan YL, Chan JC, Chan WB, Kong WL, Int J Obes (Lond) 2006 30 787 793 10.1038/sj.ijo.0803201
17. Sonographic measurement of mesenteric fat thickness is a good correlate with cardiovascular risk factors: comparison with subcutaneous and preperitoneal fat thickness, magnetic resonance imaging and anthropometric indexes. Liu KH, Chan YL, Chan WB, Kong WL, Kong MO, Chan JC, Int J Obes Relat Metab Disord 2003 27 1267 1273 10.1038/sj.ijo.0802398 14513076
18. Normal anatomy and pathologic changes of the small bowel mesentery: US appearance. Derchi LE, Solbiati L, Rizzatto G, De Pra L, Radiology 1987 164 649 652 3303119
19. Sonographic measurement of mesenteric fat predicts presence of fatty liver among subjects with polycystic ovary syndrome. Ma RC, Liu KH, Lam PM, Cheung LP, Tam WH, Ko GT, Chan MH, Ho CS, Lam CW, Chu WC, et al. J Clin Endocrinol Metab 2011 96 799 807 10.1210/jc.2010-1608 21190980
20. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ, J Clin Invest 2005 115 1343 1351 15864352
21. Normalization of visceral adiposity is required to normalize plasma apolipoprotein B levels in response to a healthy eating/physical activity lifestyle modification program in viscerally obese men. Pelletier-Beaumont E, Arsenault BJ, Almeras N, Bergeron J, Tremblay A, Poirier P, Despres JP, Atherosclerosis 2012 221 577 582 10.1016/j.atherosclerosis.2012.01.023 22321874
22. Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease. Despres JP, Moorjani S, Lupien PJ, Tremblay A, Nadeau A, Bouchard C, Arteriosclerosis 1990 10 497 511 10.1161/01.ATV.10.4.497 2196040
23. Effect of weight loss on HDL-apoA-II kinetics in the metabolic syndrome. Ng TW, Chan DC, Barrett PH, Watts GF, Clin Sci (Lond) 2010 118 79 85
24. Metabolic abnormalities: triglyceride and low-density lipoprotein. Krauss RM, Siri PW, Endocrinol Metab Clin North Am 2004 33 405 415 10.1016/j.ecl.2004.03.016 15158526
25. Hepatic insulin resistance, metabolic syndrome and cardiovascular disease. Meshkani R, Adeli K, Clin Biochem 2009 42 1331 1346 10.1016/j.clinbiochem.2009.05.018 19501581
26. Adipocyte signaling and lipid homeostasis: sequelae of insulin-resistant adipose tissue. Yu YH, Ginsberg HN, Circ Res 2005 96 1042 1052 10.1161/01.RES.0000165803.47776.38 15920027
27. Neuropeptides, mesenteric fat, and intestinal inflammation. Karagiannides I, Pothoulakis C, Ann N Y Acad Sci 2008 1144 127 135 10.1196/annals.1418.009 19076372
28. Upregulation of apolipoprotein B secretion, but not lipid, by tumor necrosis factor-alpha in rat hepatocyte cultures in the absence of extracellular fatty acids. Bartolome N, Rodriguez L, Martinez MJ, Ochoa B, Chico Y, Ann N Y Acad Sci 2007 1096 55 69 10.1196/annals.1397.070 17405916
29. Adipocytokines and VLDL metabolism: independent regulatory effects of adiponectin, insulin resistance, and fat compartments on VLDL apolipoprotein B-100 kinetics? Ng TW, Watts GF, Farvid MS, Chan DC, Barrett PH, Diabetes 2005 54 795 802 10.2337/diabetes.54.3.795 15734858
30. Adipocytokines and insulin resistance. Pittas AG, Joseph NA, Greenberg AS, J Clin Endocrinol Metab 2004 89 447 452 10.1210/jc.2003-031005 14764746
31. Tumor necrosis factor-alpha directly stimulates the overproduction of hepatic apolipoprotein B100-containing VLDL via impairment of hepatic insulin signaling. Qin B, Anderson RA, Adeli K, Am J Physiol Gastrointest Liver Physiol 2008 294 1120 G1129 10.1152/ajpgi.00407.2007 18372392
32. Increased plasma cholesteryl ester transfer protein in obese subjects. A possible mechanism for the reduction of serum HDL cholesterol levels in obesity. Arai T, Yamashita S, Hirano K, Sakai N, Kotani K, Fujioka S, Nozaki S, Keno Y, Yamane M, Shinohara E, et al. Arterioscler Thromb 1994 14 1129 1136 10.1161/01.ATV.14.7.1129 8018669
33. Visceral fat accumulation contributes to insulin resistance, small-sized low-density lipoprotein, and progression of coronary artery disease in middle-aged non-obese Japanese men. Kobayashi H, Nakamura T, Miyaoka K, Nishida M, Funahashi T, Yamashita S, Matsuzawa Y, Jpn Circ J 2001 65 193 199 10.1253/jcj.65.193 11266194
34. The implication of obesity and central fat on markers of chronic inflammation: the ATTICA study. Panagiotakos DB, Pitsavos C, Yannakoulia M, Chrysohoou C, Stefanadis C, Atherosclerosis 2005 183 308 315 10.1016/j.atherosclerosis.2005.03.010 16285994